Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'proton pump inhibitor' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 321 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hendriks, JJE; Kester, ADM; Donckerwolcke, R; Forget, PP; Wouters, EFM
      Changes in pulmonary hyperinflation and bronchial hyperresponsiveness following treatment with lansoprazole in children with cystic fibrosis

      PEDIATRIC PULMONOLOGY
    2. McCarthy, DM
      Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    3. Labenz, J
      Current role of acid suppressants in Helicobacter pylori eradication therapy

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    4. van Leerdam, ME; Rauws, EAJ
      The role of acid suppressants in upper gastrointestinal ulcer bleeding

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    5. Gillen, D; McColl, KEL
      Problems related to acid rebound and tachyphylaxis

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    6. Meuwissen, SGM; Craanen, ME; Kuipers, EJ
      Gastric mucosal morphological consequences of acid suppression: a balancedview

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    7. Katsuki, H; Hamada, A; Nakamura, C; Arimori, K; Nakano, M
      High-performance liquid chromatographic assay for the simultaneous determination of lansoprazole enantiomers and metabolites in human liver microsomes

      JOURNAL OF CHROMATOGRAPHY B
    8. Williamson, JS
      Helicobacter pylori: Current chemotherapy and new targets for drug design

      CURRENT PHARMACEUTICAL DESIGN
    9. Moayyedi, P; Murphy, B
      Helicobacter pylori: a clinical update

      JOURNAL OF APPLIED MICROBIOLOGY
    10. de Boer, WA
      A novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    11. Gomollon, F; Sicilia, B
      Helicobacter pylori: strategies for treatment

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    12. Pilotto, A
      Helicobacter pylori-associated peptic ulcer disease in older patients - Current management strategies

      DRUGS & AGING
    13. McCarthy, DM
      Helicobacter pylori and NSAIDs - What interaction

      EUROPEAN JOURNAL OF SURGERY
    14. Asaka, M; Satoh, K; Sugano, K; Sugiyama, T; Takahashi, S; Fukuda, Y; Ota, H; Murakami, K; Kimura, K; Shimoyama, T
      Guidelines in the management of Helicobacter pylori infection in Japan

      HELICOBACTER
    15. Ohara, T; Goshi, S; Taneike, I; Tamura, Y; Zhang, HM; Yamamoto, T
      Inhibitory action of a novel proton pump inhibitor, rabeprazole, and its thioether derivative against the growth and motility of clarithromycin-resistant Helicobacter pylori

      HELICOBACTER
    16. Gisbert, JP; Marcos, S; Gisbert, JL; Pajares, JM
      High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori eradication

      HELICOBACTER
    17. Miehsler, W; Puspok, A; Oberhuber, G; Vogelsang, H
      Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract

      INFLAMMATORY BOWEL DISEASES
    18. Dixit, C; Dikshit, M
      A flowcytometric method for evaluation of acid secretion from isolated ratgastric mucosal cells

      JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
    19. Furuta, T; Shirai, N; Takashima, M; Xiao, F; Hanai, H; Nakagawa, K; Sugimura, H; Ohashi, K; Ishizaki, T
      Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin

      PHARMACOGENETICS
    20. van Rensburg, CJ; Bardhan, KD
      No clinical benefit of adding cisapride to pantoprazole for treatment of gastro-oesophageal reflux disease

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    21. Hsu, CC; Chen, JJ; Hu, TH; Lu, SN; Changchien, CS
      Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    22. de Boer, WA; Tytgat, GNJ
      Should anti-Helicobacter therapy be different in patients with dyspepsia compared with patients with peptic ulcer diathesis?

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    23. Lundell, L
      Gastro-oesophageal reflux disease and Helicobacter pylori or gastro-oesophageal reflux disease from Helicobacter pylori?

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    24. Robinson, M
      New-generation proton pump inhibitors: overcoming the limitations of early-generation agents

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    25. Schaltenbrand, R; Huber, R; Cotoraci, CA; Mascher, H; Potthast, H; Hole, U
      Bioequivalence between omeprazole MUPS 20 mg as tablet and omeprazole MUPS20 mg as tablet encapsulated in a hard gelatine capsule

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    26. Yamada, S; Onda, M; Kato, S; Matsuda, N; Matsuhisa, T; Yamada, N; Miki, M; Matsukura, N
      Genetic differences in CYP2C19 single nucleotide polymorphisms among four Asian populations

      JOURNAL OF GASTROENTEROLOGY
    27. Claessens, AAMC; Heerdink, ER; Lamers, CBHW; van Eijk, JTM; Leufkens, HGM
      Factors associated with non-response in proton pump inhibitor users: a study of lansoprazole therapy

      PHARMACY WORLD & SCIENCE
    28. Masa, K; Hamada, A; Arimori, K; Fujii, J; Nakano, M
      Pharmacokinetic differences between lansoprazole enantiomers and contribution of cytochrome P450 isoforms to enantioselective metabolism of lansoprazole in dogs

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    29. Sakai, T; Aoyama, N; Kita, T; Sakaeda, T; Nishiguchi, K; Nishitora, Y; Hohda, T; Sirasaka, D; Tamura, T; Tanigawara, Y; Kasuga, M; Okumura, K
      CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects

      PHARMACEUTICAL RESEARCH
    30. Ley, LM; Stahlheber-Dilg, B; Sander, P; Huber, R; Mascher, H; Lucker, PW
      Bioavailability of a crushed pantoprazole tablet after buffering with sodium hydrogencarbonate or magaldrate relative to the intact enteric coated pantoprazole tablet

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    31. Andersson, T; Hassan-Alin, M; Hasselgren, G; Rohss, K; Weidolf, L
      Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole

      CLINICAL PHARMACOKINETICS
    32. Goldstein, JA
      Clinical relevance of genetic polymorphisms in the human CYP2C subfamily

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    33. Calvet, X; Garcia, N; Gene, E; Campo, R; Brullet, E; Sanfeliu, I
      Modified seven-day, quadruple therapy as a first line Helicobacter pylori treatment

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    34. Pilotto, A; O'Morain, C
      Treatment of Helicobacter pylori infection

      CURRENT OPINION IN GASTROENTEROLOGY
    35. Gisbert, JP; Pajares, JM
      Helicobacter pylori therapy: First-line options and rescue regimen

      DIGESTIVE DISEASES
    36. Raisch, DW; Klaurens, LM; Hayden, C; Malagon, I; Pulliam, G; Fass, R
      Impact of a formulary change in proton pump inhibitors on health care costs and patients' symptoms

      DIGESTIVE DISEASES AND SCIENCES
    37. Zimmermann, AE; Walters, JK; Katona, BG; Souney, PF; Levine, D
      A review of omeprazole use in the treatment of acid-related disorders in children

      CLINICAL THERAPEUTICS
    38. Yoshida, T; Kito, M; Tsujii, M; Nagasawa, T
      Microbial synthesis of a proton pump inhibitor by enantioselective oxidation of a sulfide into its corresponding sulfoxide by Cunninghamella echinulata MK40

      BIOTECHNOLOGY LETTERS
    39. Nagata, K; Sone, N; Tamura, T
      Inhibitory activities of lansoprazole against respiration in Helicobacter pylori

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    40. Luth, S; Teyssen, S; Kolbel, CB; Singer, MV
      4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease- A pilot study

      ZEITSCHRIFT FUR GASTROENTEROLOGIE
    41. Ieiri, I; Kishimoto, Y; Okochi, H; Momiyama, K; Morita, T; Kitano, M; Morisawa, T; Fukushima, Y; Nakagawa, K; Hasegawa, J; Otsubo, K; Ishizaki, T
      Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    42. Yildirim, K; Sarioglu, Y; Kaya, T; Cetin, A; Yildirim, S
      Inhibitor effect of omeprazole in isolated human myometrial smooth muscle

      LIFE SCIENCES
    43. Noordzij, JP; Khidr, A; Evans, BA; Desper, E; Mittal, RK; Reibel, JF; Levine, PA
      Evaluation of omeprazole in the treatment of reflux laryngitis: A prospective, placebo-controlled, randomized, double-blind study

      LARYNGOSCOPE
    44. Hawkey, GM; Cole, AT; McIntyre, AS; Long, RG; Hawkey, CJ
      Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points

      GUT
    45. Carriere, F; Renou, C; Ville, E; Grandval, P; Laugier, R
      Advantage of expressing the variations in some digestive parameters as a function of gastric emptying instead of time

      DIGESTION
    46. Kaspari, S; Biedermann, A; Mey, J
      Comparison of pantoprazole 20 mg to ranitidine 150 mg bid in the treatmentof mild gastroesophageal reflux disease

      DIGESTION
    47. Lee, EB; Cho, SI; Chang, HO; Chang, MS; Kim, KB; Lee, SB; Choi, WS
      General pharmacological properties of YJA20379-8, a new H+/K+-ATPase inhibitor with anti-ulcer activities

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    48. Kim, EJ; Lee, RK; Lee, SM; Kim, DY
      General pharmacology of IY-81149, a new proton pump inhibitor

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    49. Yardimci, C; Ozaltin, N
      Electrochemical studies and differential pulse polarographic analysis of lansoprazole in pharmaceuticals

      ANALYST
    50. Eubanks, TR; Omelanczuk, P; Hillel, A; Maronian, N; Pope, CE; Pellegrini, CA
      Pharyngeal pH measurements in patients with respiratory symptoms before and during proton pump inhibitor therapy

      AMERICAN JOURNAL OF SURGERY
    51. Armstrong, D; Pare, P; Pericak, D; Pyzyk, M
      Symptom relief in gastroesophageal reflux disease: A randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    52. Malfertheiner, P; Brucks, U; Peitz, U
      Ulcerative disease and dyspepsia: which treatment is proven?

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    53. Vieth, M; Stolte, M
      Fundic gland polyps are not induced by proton pump inhibitor therapy

      AJCP. American journal of clinical pathology
    54. Savarino, V
      Long-term therapy of gastro-oesophageal reflux disease: medical or surgical?

      DIGESTIVE AND LIVER DISEASE
    55. van Herwaarden, MA; Smout, AJPM
      Diagnosis of reflux disease

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    56. Hawkey, CJ
      Management of gastroduodenal ulcers caused by non-steroidal anti-inflammatory drugs

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    57. Nakajima, S; Graham, DY; Hattori, T; Bamba, T
      Strategy for treatment of Helicobacter pylori infection in adults II. Practical policy in 2000

      CURRENT PHARMACEUTICAL DESIGN
    58. Kato, M; Hokari, K; Kagaya, H; Takeda, H; Sugiyama, T; Asaka, M
      Traditional and non-traditional antimicrobial agents for H-pylori infection

      CURRENT PHARMACEUTICAL DESIGN
    59. Nagahara, A; Miwa, H; Ogawa, K; Kurosawa, A; Ohkura, R; Iida, N; Sato, N
      Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy

      HELICOBACTER
    60. Birbara, C; Breiter, J; Perdomo, C; Hahne, W
      Rabeprazole for the prevention of recurrent erosive or ulcerative gastro-oesophageal reflux disease

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    61. Plein, K; Hotz, J; Wurzer, H; Fumagalli, I; Luhmann, R; Schneider, A
      Pantoprazole 20 mg is an effective maintenance therapy for patients with gastro-oesophageal reflux disease

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    62. Omura, N; Kashiwagi, H; Chen, G; Yano, F; Suzuki, Y; Aoki, T
      Effects of ecabet sodium on experimentally induced reflux esophagitis

      JOURNAL OF GASTROENTEROLOGY
    63. Miwa, H; Murai, T; Sato, K; Ohkura, R; Yamada, T; Nagahara, A; Ohtaka, K; Minowa, T; Kurosawa, A; Sato, N
      Comparison of the efficacy of 400 mg and 800 mg of clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection in a Japanese population

      JOURNAL OF GASTROENTEROLOGY
    64. Kaneko, E; Hoshihara, Y; Sakaki, N; Harasawa, S; Ashida, K; Asaka, M; Asaki, S; Nakamura, T; Kobayashi, K; Kajiyama, G; Ogawa, N; Yao, T; Muto, Y; Nakazawa, S; Takemoto, T
      Peptic ulcer recurrence during maintenance therapy with H-2-receptor antagonist following first-line therapy with proton pump inhibitor

      JOURNAL OF GASTROENTEROLOGY
    65. Bastaki, SMA; Chandranath, I; Garner, A
      Comparison of five antisecretory agents acting via gastric H+/K+-ATPase

      JOURNAL OF PHYSIOLOGY-PARIS
    66. Megraud, F
      Strategies to treat patients with antibiotic resistant Helicobacter pylori

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    67. Heudebert, GR; Centor, RM; Klapow, JC; Marks, R; Johnson, L; Wilcox, CM
      What is heartburn worth? A cost-utility analysis of management strategies

      JOURNAL OF GENERAL INTERNAL MEDICINE
    68. Yoshinaga, M; Ohtani, A; Tsuruta, S; Kato, T; Higashi, E; Yamada, Y; Harada, N; Nawata, H
      Effect of acid-suppressive therapy on Helicobacter pylori production of interleukin-8 in the gastric mucosa

      CANADIAN JOURNAL OF GASTROENTEROLOGY
    69. Chiba, N; Thomson, ABR; Sinclair, P
      From bench to bedside to bug: An update of clinically relevant advances inthe care of persons with Helicobacter pylori-associated diseases

      CANADIAN JOURNAL OF GASTROENTEROLOGY
    70. Vandenplas, Y; Hegar, B
      Diagnosis and treatment of gastro-oesophageal reflux disease in infants and children

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    71. Blandizzi, C; Natale, G; Gherardi, G; Lazzeri, G; Marveggio, C; Colucci, R; Carignani, D; Del Tacca, N
      Gastroprotective effects of pantoprazole against experimental mucosal damage

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    72. Suzuki, K; Tsuyuguchi, K; Matsumoto, H; Niimi, A; Tanaka, E; Amitani, R
      Effect of proton pump inhibitor alone or in combination with clarithromycin on mycobacterial growth in human alveolar macrophages

      FEMS MICROBIOLOGY LETTERS
    73. Klotz, U
      Pharmacokinetic considerations in the eradication of Helicobacter pylori

      CLINICAL PHARMACOKINETICS
    74. Tassaneeyakul, W; Tassaneeyakul, W; Vannaprasaht, S; Yamazoe, Y
      Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    75. Kihira, K; Satoh, K; Saifuku, K; Kawakami, S; Fukazawa, K; Ishino, Y; Kimura, K; Sugano, K
      Rabeprazole, amoxycillin and low- or high-dose clarithromycin for cure of Helicobacter pylori infection

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    76. Williams, MP; Blanshard, C; Millson, C; Sercombe, J; Pounder, RE
      A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin inhealthy male subjects

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    77. Savarino, V; Bisso, G; Pivari, M; Zentilin, P; Bilardi, C; Dulbecco, P; Mele, MR; Tracci, D; Vigneri, S
      Effect of gastric acid suppression on C-13-urea breath test: comparison ofranitidine with omeprazole

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    78. Isomoto, H; Furusu, H; Morikawa, T; Mizuta, Y; Nishiyama, T; Omagari, K; Murase, K; Inoue, K; Murata, I; Kohno, S
      5-day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    79. Adachi, K; Katsube, T; Kawamura, A; Takashima, T; Yuki, M; Amano, K; Ishihara, S; Fukuda, R; Watanabe, M; Kinoshita, Y
      CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    80. Cammarota, G; Cianci, R; Cannizzaro, O; Cuoco, L; Pirozzi, G; Gasbarrini, A; Armuzzi, A; Zocco, MA; Santarelli, L; Arancio, F; Gasbarrini, G
      Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    81. Waldum, HL; Brenna, E
      Is profound acid inhibition safe?

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    82. Sampliner, RE
      Reduction of acid exposure and regression of Barrett's esophagus

      DIGESTIVE DISEASES
    83. DeVault, KR
      What is the optimal medical therapy for Barrett's esophagus?

      DIGESTIVE DISEASES
    84. Lee, EB; Cho, SI; Cheon, SA; Chang, MS; Kim, KB; Woo, TW; Chung, YK
      General pharmacological properties of YJA20379-2, a new antiulcer agent

      ARCHIVES OF PHARMACAL RESEARCH
    85. Bock, H; Koop, H; Lehn, N; Heep, M
      Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment - Preliminary experience

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    86. Ng, FH; Wong, SY; Ng, WF; Wong, BCY
      Prolonged storage of frozen unbuffered rapid urease test

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    87. Kawamura, T; Miyaji, C; Toyabe, S; Fukuda, M; Watanabe, H; Abo, T
      Suppressive effect of antiulcer agents on granulocytes - A role for granulocytes in gastric ulcer formation

      DIGESTIVE DISEASES AND SCIENCES
    88. Sheu, BS; Lee, SC; Yang, HB; Kuo, AW; Wang, YL; Shiesh, SC; Wu, JJ; Lin, XZ
      Selection of lower cutoff point of [C-13]urea breath test is helpful to monitor H-pylori eradication after proton pump inhibitor-based triple therapy

      DIGESTIVE DISEASES AND SCIENCES
    89. Bonapace, ES; Fisher, RS; Parkman, HP
      Does fasting serum gastrin predict gastric acid suppression in patients onproton-pump inhibitors?

      DIGESTIVE DISEASES AND SCIENCES
    90. Miwa, H; Yamada, T; Sato, K; Ohta, K; Ohkura, R; Murai, T; Nagahara, A; Takei, Y; Ogihara, T; Sato, N
      Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection - Comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole

      DIGESTIVE DISEASES AND SCIENCES
    91. Vivian, EM; Thompson, MA
      Pharmacologic strategies for treating gastroesophageal reflux disease

      CLINICAL THERAPEUTICS
    92. Avner, DL
      Clinical experience with pantoprazole in gastroesophageal reflux disease

      CLINICAL THERAPEUTICS
    93. Abelo, A; Andersson, TB; Antonsson, M; Naudot, AK; Skanberg, I; Weidolf, L
      Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes

      DRUG METABOLISM AND DISPOSITION
    94. Manifold, DK; Marshall, REK; Anggiansah, A; Owen, WJ
      Effect of omeprazole on antral duodenogastric reflux in Barrett oesophagus

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    95. Delchier, JC; Cohen, G; Humphries, TJ
      Rabeprazole, 20 mg once daily or 10 mg twice daily, is equivalent to omeprazole, 20 mg once daily, in the healing of erosive gastrooesophageal refluxdisease

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    96. Burgess, MI; Densem, CG; Brooks, NH; Levy, RD; Lee, HS
      The real cost of aspirin

      POSTGRADUATE MEDICAL JOURNAL
    97. Wedlund, PJ
      The CYP2C19 enzyme polymorphism

      PHARMACOLOGY
    98. Shiotani, A; Nurgalieva, ZZ; Yamaoka, Y; Graham, DY
      Helicobacter pylori

      MEDICAL CLINICS OF NORTH AMERICA
    99. Tsukimi, Y; Ushiro, T; Yamazaki, T; Ishikawa, H; Hirase, J; Narita, M; Nishigaito, T; Banno, K; Ichihara, T; Tanaka, H
      Studies on the mechanism of action of the gastric H+,K+-ATPase inhibitor SPI-447

      JAPANESE JOURNAL OF PHARMACOLOGY
    100. Ono, K; Sawada, T; Murata, Y; Saito, E; Iwasaki, A; Arakawa, Y; Kurokawa, K; Hashimoto, Y
      Pentagalloylglucose, an antisecretory component of Paeoniae radix, inhibits gastric H+, K+-ATPase

      CLINICA CHIMICA ACTA


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/02/20 alle ore 11:14:04